Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Safeguarding genome integrity : the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. / Sørensen, Claus Storgaard; Syljuåsen, Randi G.

I: Nucleic Acids Research, Bind 40, Nr. 2, 2012, s. 477-86.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sørensen, CS & Syljuåsen, RG 2012, 'Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication', Nucleic Acids Research, bind 40, nr. 2, s. 477-86. https://doi.org/10.1093/nar/gkr697

APA

Sørensen, C. S., & Syljuåsen, R. G. (2012). Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Research, 40(2), 477-86. https://doi.org/10.1093/nar/gkr697

Vancouver

Sørensen CS, Syljuåsen RG. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Research. 2012;40(2):477-86. https://doi.org/10.1093/nar/gkr697

Author

Sørensen, Claus Storgaard ; Syljuåsen, Randi G. / Safeguarding genome integrity : the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. I: Nucleic Acids Research. 2012 ; Bind 40, Nr. 2. s. 477-86.

Bibtex

@article{10e25f4463f04b598b6c9e8de75baf74,
title = "Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication",
abstract = "Mechanisms that preserve genome integrity are highly important during the normal life cycle of human cells. Loss of genome protective mechanisms can lead to the development of diseases such as cancer. Checkpoint kinases function in the cellular surveillance pathways that help cells to cope with DNA damage. Importantly, the checkpoint kinases ATR, CHK1 and WEE1 are not only activated in response to exogenous DNA damaging agents, but are active during normal S phase progression. Here, we review recent evidence that these checkpoint kinases are critical to avoid deleterious DNA breakage during DNA replication in normal, unperturbed cell cycle. Possible mechanisms how loss of these checkpoint kinases may cause DNA damage in S phase are discussed. We propose that the majority of DNA damage is induced as a consequence of deregulated CDK activity that forces unscheduled initiation of DNA replication. This could generate structures that are cleaved by DNA endonucleases leading to the formation of DNA double-strand breaks. Finally, we discuss how these S phase effects may impact on our understanding of cancer development following disruption of these checkpoint kinases, as well as on the potential of these kinases as targets for cancer treatment.",
keywords = "Animals, Cell Cycle Proteins, Cell Transformation, Neoplastic, Cyclin-Dependent Kinases, DNA Damage, DNA Replication, Genome, Humans, Mice, Nuclear Proteins, Protein Kinases, Protein-Serine-Threonine Kinases, Protein-Tyrosine Kinases",
author = "S{\o}rensen, {Claus Storgaard} and Sylju{\aa}sen, {Randi G}",
year = "2012",
doi = "10.1093/nar/gkr697",
language = "English",
volume = "40",
pages = "477--86",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Safeguarding genome integrity

T2 - the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication

AU - Sørensen, Claus Storgaard

AU - Syljuåsen, Randi G

PY - 2012

Y1 - 2012

N2 - Mechanisms that preserve genome integrity are highly important during the normal life cycle of human cells. Loss of genome protective mechanisms can lead to the development of diseases such as cancer. Checkpoint kinases function in the cellular surveillance pathways that help cells to cope with DNA damage. Importantly, the checkpoint kinases ATR, CHK1 and WEE1 are not only activated in response to exogenous DNA damaging agents, but are active during normal S phase progression. Here, we review recent evidence that these checkpoint kinases are critical to avoid deleterious DNA breakage during DNA replication in normal, unperturbed cell cycle. Possible mechanisms how loss of these checkpoint kinases may cause DNA damage in S phase are discussed. We propose that the majority of DNA damage is induced as a consequence of deregulated CDK activity that forces unscheduled initiation of DNA replication. This could generate structures that are cleaved by DNA endonucleases leading to the formation of DNA double-strand breaks. Finally, we discuss how these S phase effects may impact on our understanding of cancer development following disruption of these checkpoint kinases, as well as on the potential of these kinases as targets for cancer treatment.

AB - Mechanisms that preserve genome integrity are highly important during the normal life cycle of human cells. Loss of genome protective mechanisms can lead to the development of diseases such as cancer. Checkpoint kinases function in the cellular surveillance pathways that help cells to cope with DNA damage. Importantly, the checkpoint kinases ATR, CHK1 and WEE1 are not only activated in response to exogenous DNA damaging agents, but are active during normal S phase progression. Here, we review recent evidence that these checkpoint kinases are critical to avoid deleterious DNA breakage during DNA replication in normal, unperturbed cell cycle. Possible mechanisms how loss of these checkpoint kinases may cause DNA damage in S phase are discussed. We propose that the majority of DNA damage is induced as a consequence of deregulated CDK activity that forces unscheduled initiation of DNA replication. This could generate structures that are cleaved by DNA endonucleases leading to the formation of DNA double-strand breaks. Finally, we discuss how these S phase effects may impact on our understanding of cancer development following disruption of these checkpoint kinases, as well as on the potential of these kinases as targets for cancer treatment.

KW - Animals

KW - Cell Cycle Proteins

KW - Cell Transformation, Neoplastic

KW - Cyclin-Dependent Kinases

KW - DNA Damage

KW - DNA Replication

KW - Genome

KW - Humans

KW - Mice

KW - Nuclear Proteins

KW - Protein Kinases

KW - Protein-Serine-Threonine Kinases

KW - Protein-Tyrosine Kinases

U2 - 10.1093/nar/gkr697

DO - 10.1093/nar/gkr697

M3 - Journal article

C2 - 21937510

VL - 40

SP - 477

EP - 486

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 2

ER -

ID: 40794618